NCT07492914 2026-03-25
Neoadjuvant Sacituzumab Govitecan Plus Tagitanlimab for Resectable Head and Neck Squamous Cell Carcinoma
West China Hospital
Phase 2 Not yet recruiting
Clinical Trials
5 trialsNCT05884320 2026-03-20
Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland Cancers
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT07063212 2026-02-19
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT06923826 2025-07-25
TROP2
National University Hospital, Singapore
Phase 2 Recruiting
NCT06235216 2024-11-01
SETHY
Grupo Espanol de Tumores Neuroendocrinos
Phase 2 Recruiting